Literature DB >> 12483033

IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity.

Adriano Mari1.   

Abstract

BACKGROUND: IgE to cross-reacting carbohydrate determinants has already been described by several authors, but their function and distribution are still a matter of debate. In previous studies we showed how the presence of IgE to bromelain could be a useful and simple marker of the presence of IgE to carbohydrate epitopes.
METHODS: A survey of 1,831 subjects with a suspected allergic respiratory disease has been carried out by detecting IgE to bromelain. Data were analysed on the basis of demographical and allergological parameters. To find out whether a glycoprotein is capable of triggering an allergic reaction, 1,076 subjects were also skin tested with several purified molecules bearing carbohydrate side chains differing in number, composition and complexity.
RESULTS: An overall prevalence of 23% of positive IgE to cross-reacting carbohydrate determinants was recorded. Prevalence varied when subsets of non-allergic (5%), non-pollen-allergic (10%), and pollen-allergic (31%) subjects were considered. Prevalence further increased in subsets with multiple pollen sensitization (71%), and with a previous pollen immunotherapy course (46%), whereas minor differences were found in gender and age distribution. Almost all the allergenic extracts recorded negative in the skin test gave a positive IgE test in vitro. A higher correlation was found mainly with plant-derived allergenic extracts, whereas a lower one was recorded with mites and fungi. Horseradish peroxidase was the only glycoprotein capable of exerting a positive skin test in 21% of the subjects with IgE to cross-reacting carbohydrate determinants, 80% of them having IgE to the HRP molecule.
CONCLUSIONS: IgE to cross-reacting carbohydrate determinants are common among the allergic population and the binding to skin test negative allergenic extracts further confirms their poor biological activity. Further studies on horseradish peroxidase should be carried out to define the role of the glycan side chains in its allergenic activity. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483033     DOI: 10.1159/000067591

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  42 in total

1.  The role of anti-CCD antibodies in grape allergy diagnosis.

Authors:  Reza Falak; Mojtaba Sankian; Hanieh Ketabdar; Malihe Moghadam; Abdol-Reza Varasteh
Journal:  Rep Biochem Mol Biol       Date:  2013-04

Review 2.  Determinants of food allergy.

Authors:  Madhan Masilamani; Scott Commins; Wayne Shreffler
Journal:  Immunol Allergy Clin North Am       Date:  2012-02       Impact factor: 3.479

Review 3.  The alpha-gal story: lessons learned from connecting the dots.

Authors:  John W Steinke; Thomas A E Platts-Mills; Scott P Commins
Journal:  J Allergy Clin Immunol       Date:  2015-03       Impact factor: 10.793

4.  Allergenicity of carbohydrates and their role in anaphylactic events.

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

Review 5.  Carbohydrates as allergens.

Authors:  Scott P Commins
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

Review 6.  Glycoprotein production in moss bioreactors.

Authors:  Eva L Decker; Ralf Reski
Journal:  Plant Cell Rep       Date:  2011-09-29       Impact factor: 4.570

7.  Glycoproteomic analysis of seven major allergenic proteins reveals novel post-translational modifications.

Authors:  Adnan Halim; Michael C Carlsson; Caroline Benedicte Madsen; Stephanie Brand; Svenning Rune Møller; Carl Erik Olsen; Sergey Y Vakhrushev; Jens Brimnes; Peter Adler Wurtzen; Henrik Ipsen; Bent L Petersen; Hans H Wandall
Journal:  Mol Cell Proteomics       Date:  2014-11-11       Impact factor: 5.911

Review 8.  Delayed anaphylaxis to red meat masquerading as idiopathic anaphylaxis.

Authors:  Anubha Tripathi; Scott P Commins; Peter W Heymann; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol Pract       Date:  2014 May-Jun

9.  Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity.

Authors:  Henning Seismann; Simon Blank; Liliana Cifuentes; Ingke Braren; Reinhard Bredehorst; Thomas Grunwald; Markus Ollert; Edzard Spillner
Journal:  Clin Mol Allergy       Date:  2010-04-01

10.  Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic Development.

Authors:  Li Xue; Adrienne Clements-Egan; Lakshmi Amaravadi; Mary Birchler; Boris Gorovits; Meina Liang; Heather Myler; Shobha Purushothama; Marta Starcevic Manning; Crystal Sung
Journal:  AAPS J       Date:  2017-11-06       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.